DE69828817D1 - Pharmazeutische aerosolzusammensetzungen - Google Patents

Pharmazeutische aerosolzusammensetzungen

Info

Publication number
DE69828817D1
DE69828817D1 DE69828817T DE69828817T DE69828817D1 DE 69828817 D1 DE69828817 D1 DE 69828817D1 DE 69828817 T DE69828817 T DE 69828817T DE 69828817 T DE69828817 T DE 69828817T DE 69828817 D1 DE69828817 D1 DE 69828817D1
Authority
DE
Germany
Prior art keywords
drug
aerosol compositions
pharmaceutical aerosol
propellant
aerosol formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69828817T
Other languages
English (en)
Other versions
DE69828817T2 (de
Inventor
Yvonne Pritchard
Singh Claire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of DE69828817D1 publication Critical patent/DE69828817D1/de
Publication of DE69828817T2 publication Critical patent/DE69828817T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69828817T 1997-12-08 1998-11-20 Pharmazeutische aerosolzusammensetzungen Expired - Lifetime DE69828817T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9725984A GB2332372B (en) 1997-12-08 1997-12-08 Pharmaceutical aerosol compositions
GB9725984 1997-12-08
PCT/GB1998/003488 WO1999029296A1 (en) 1997-12-08 1998-11-20 Pharmaceutical aerosol compositions

Publications (2)

Publication Number Publication Date
DE69828817D1 true DE69828817D1 (de) 2005-03-03
DE69828817T2 DE69828817T2 (de) 2006-05-18

Family

ID=10823304

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69828817T Expired - Lifetime DE69828817T2 (de) 1997-12-08 1998-11-20 Pharmazeutische aerosolzusammensetzungen

Country Status (11)

Country Link
EP (1) EP1037604B1 (de)
JP (1) JP5384776B2 (de)
AT (1) ATE287699T1 (de)
AU (1) AU759746B2 (de)
BR (1) BRPI9813397B8 (de)
CA (1) CA2311450C (de)
DE (1) DE69828817T2 (de)
ES (1) ES2234165T3 (de)
GB (1) GB2332372B (de)
PT (1) PT1037604E (de)
WO (1) WO1999029296A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0820323T3 (da) * 1995-04-14 2003-11-24 Smithkline Beecham Corp Inhalator til afmålte doser af salmeterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6423298B2 (en) 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
DE60031504T2 (de) * 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
DE60019167T2 (de) * 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5715640B2 (ja) 2009-11-25 2015-05-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US20120272951A1 (en) * 2009-12-16 2012-11-01 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
EP2585151B1 (de) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Vernebler
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
EP3139984B1 (de) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Zerstäuber
MX2016014399A (es) 2014-05-07 2017-01-20 Boehringer Ingelheim Int Nebulizador.
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006675A1 (en) * 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
CZ300910B6 (cs) * 1998-06-18 2009-09-09 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostredek

Also Published As

Publication number Publication date
AU759746B2 (en) 2003-05-01
PT1037604E (pt) 2005-05-31
BRPI9813397B1 (pt) 2011-08-23
EP1037604B1 (de) 2005-01-26
DE69828817T2 (de) 2006-05-18
EP1037604A1 (de) 2000-09-27
GB2332372B (en) 2002-08-14
BRPI9813397B8 (pt) 2021-07-06
GB2332372A (en) 1999-06-23
ATE287699T1 (de) 2005-02-15
JP5384776B2 (ja) 2014-01-08
CA2311450C (en) 2009-05-05
JP2001525354A (ja) 2001-12-11
GB9725984D0 (en) 1998-02-04
WO1999029296A1 (en) 1999-06-17
BRPI9813397A (pt) 2000-10-10
ES2234165T3 (es) 2005-06-16
CA2311450A1 (en) 1999-06-17
AU1248699A (en) 1999-06-28

Similar Documents

Publication Publication Date Title
ATE287699T1 (de) Pharmazeutische aerosolzusammensetzungen
ATE291898T1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
ATE343374T1 (de) Fluticasonpropionat arzneizubereitung
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
HUP0102468A2 (hu) Nyomás alatti dózisadagoló inhaláló berendezés és aeroszol formájú gyógyászati készítmények
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
NZ298169A (en) Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
NO307864B1 (no) Farmasøytisk aerosolformulering, boks og doseringsinhalator
WO1995017156A3 (en) Ethanol substitutes
SE0002643L (sv) Inhalationsberedningar innehållande mikropartiklar
ATE180665T1 (de) Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
DE60017450D1 (de) Pharmazeutische formulierungen enthaltend salmeterol
MX9707238A (es) Formulaciones en aerosol de butixocort.
ITBA920007A0 (it) Formulazioni farmaceutiche per la somminstrazione sistemica per via nasale degli ormoni sessuali femminili naturali e di ormoni ad attivita' estrogenica e/o progestativa sia naturali che di sintesi.
CA2446562A1 (en) Pharmaceutical formulation of fluticasone propionate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition